You are viewing:
Information released online before January, 2021.
Note: Content in this archive site is NOT UPDATED, and external links may not function. External links to other Internet sites should not be construed as an endorsement of the views contained therein.
You are entering the 2017-2020 Archive for the
United States Agency for International Development web site.
If you are looking for current information, visit www.usaid.gov.
In response to declining donor funds towards ARVs, Vietnam has committed to sustaining ARV procurement using its SHI Fund. In early October, with support from USAID’s Global Health Supply Chain - Procurement and Supply Management (GHSC-PSM) project, Vietnam’s Ministry of Health successfully bid for the first procurement of ARVs through SHI. The bid package, which is valued at approximately $5.9 million, will cover medication for 48,000 HIV/AIDS patients for an entire year - the number of HIV/AIDS patients estimated to be covered by SHI in 2019. The ARVs are expected to be available in January 2019. The bidding process also resulted in a 19 percent savings due to secured purchase prices now being both competitive and comparable to the price of drugs purchased by international donors.
So What? This SHI-funded ARV procurement demonstrates Vietnam’s strong commitment to undertake financial responsibility for its HIV/AIDS program. It represents a significant milestone in the Journey to Self-Reliance in the health sector.
Comment
Make a general inquiry or suggest an improvement.